Assignee
TOKAI PHARMACEUTICALS INC
US·4 granted patents·7 pending applications·24 citations·filing 2014–2017
Top patents by PatentIndex Score
11 records- 0185US9387216B2Biomarkers for treatment of neoplastic disorders using androgen-targeted therapiesTOKAI PHARMACEUTICALS INC·Filed 2015·Granted Jul 12, 2016·9 cites·30 claims
- 0285US9359395B2Prodrugs of steroidal CYP17 inhibitors/antiandrogensTOKAI PHARMACEUTICALS INC·Filed 2014·Granted Jun 7, 2016·6 cites·9 claims
- 0385US9156878B2Treatment of prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2014·Granted Oct 13, 2015·8 cites·11 claims
- 0467US9808472B2Biomarkers for treatment of neoplastic disorders using androgen-targeted therapiesTOKAI PHARMACEUTICALS INC·Filed 2014·Granted Nov 7, 2017·1 cites·4 claims
- 0563US2015051179A1Novel steroidal cyp17 inhibitors/antiandrogensTOKAI PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0656US2017157148A1Treatment of prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0750US2015203528A1Treatment of prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0850US2015166599A1Treatment of prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0946US2017008920A1Mammalian metabolites of steroidsTOKAI PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1042US2015320770A1Novel compositions and methods for treating prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1142US2016002283A1Novel compositions and methods for treating prostate cancerTOKAI PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →